Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC

Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC ( Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira )
22 Oct 2023

Durvalumab addition to chemo shows endometrial cancer benefit

Prof Shannon Westin - University of Texas MD Anderson Cancer Center, Houston, USA
Durvalumab addition to chemo shows endometrial cancer benefit ( Prof Shannon Westin - University of Texas MD Anderson Cancer Center, Houston, USA )
21 Oct 2023

Adagrasib pembrolizumab combo shows promise for KRASG12C-positive NSCLC

Dr Pasi Janne - Dana-Farber Cancer Institute, Boston, USA
Adagrasib pembrolizumab combo shows promise for KRASG12C-positive NSCLC ( Dr Pasi Janne - Dana-Farber Cancer Institute, Boston, USA )
21 Oct 2023

Selpercatinib benefit for advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer

Dr Julien Hadoux - Institut Gustave Roussy, Villejuif, France
Selpercatinib benefit for advanced, kinase inhibitor-naïve, RET-mutant medullary thyroid cancer ( Dr Julien Hadoux - Institut Gustave Roussy, Villejuif, France )
21 Oct 2023

CheckMate-77T: Perioperative nivolumab benefit for NSCLC

Dr Tina Cascone - MD Anderson Cancer Center, Houston, USA
CheckMate-77T: Perioperative nivolumab benefit for NSCLC ( Dr Tina Cascone - MD Anderson Cancer Center, Houston, USA )
21 Oct 2023

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )
17 Oct 2023

McVie-Veronesi Awards: 2nd prize - Harnessing artificial intelligence to mitigate depression rates in cancer clinicians

Dr Srijan Das - Central Institute of Pstchiatry, Ranchi, India
McVie-Veronesi Awards: 2nd prize - Harnessing artificial intelligence to mitigate depression rates in cancer clinicians ( Dr Srijan Das - Central Institute of Pstchiatry, Ranchi, India )
12 Oct 2023

McVie-Veronesi awards: 1st Prize - Insights into journeys of cancer patients in India - Access, affordability and barriers

Ms Soumita Ghose - Tata Medical Center, Kolkata, India
McVie-Veronesi awards: 1st Prize - Insights into journeys of cancer patients in India - Access, affordability and barriers ( Ms Soumita Ghose - Tata Medical Center, Kolkata, India )
11 Oct 2023

McVie-Veronesi awards: Case reports on struma ovarii

Dr Muskan V - B.P. Koirala Institute of Health Sciences, Dharan, Nepal
McVie-Veronesi awards: Case reports on struma ovarii ( Dr Muskan V - B.P. Koirala Institute of Health Sciences, Dharan, Nepal )
11 Oct 2023

McVie-Veronesi Awards: Molecular detection of circulating types of human papillomavirus infection in West Bengal

Mr Mridul Das - Burdwan Medical College And Hospital, Burdwan, India
McVie-Veronesi Awards: Molecular detection of circulating types of human papillomavirus infection in West Bengal ( Mr Mridul Das - Burdwan Medical College And Hospital, Burdwan, India )
11 Oct 2023

McVie-Veronesi Awards: 3rd Prize - Role of sentinel lymph node biopsy in node positive breast cancer patients? Converting to node negativity after neoadjuvant chemotherapy

Dr Akella Phanedra - TATA medical center, Kolkata, India
McVie-Veronesi Awards: 3rd Prize - Role of sentinel lymph node biopsy in node positive breast cancer patients? Converting to node negativity after neoadjuvant chemotherapy ( Dr Akella Phanedra - TATA medical center, Kolkata, India )
11 Oct 2023

McVie-Veronesi Awards:Harnessing machine learning to create predictive models in mitigating disease states

Dr Akanksha Parial - Central Institute of Psychiatry, Ranchi, India
McVie-Veronesi Awards:Harnessing machine learning to create predictive models in mitigating disease states ( Dr Akanksha Parial -  Central Institute of Psychiatry, Ranchi, India )
11 Oct 2023